Connect at Cannabis Europa
Connect and collaborate with 1500+ senior politicians, scientific experts and globally respected business leaders in London.
The European Cannabis Report: 10th Edition
A deep dive into Europe’s exciting emerging cannabis market.
Business of Cannabis: Berlin
An unparalleled opportunity to elevate your leadership, drive growth, and forge powerful partnerships in the ever-evolving German and wider European cannabis landscapes.
Business of Cannabis: New York on November 12 will bring 400 industry leaders, investors, and policy makers together to drive investment and accelerate retail growth in the New York market.
Unique, highly-targeted storytelling, brand awareness and business development opportunities.
Global Medical Cannabis Market Review 2026
Pre-order data packs now and save — delivered digitally January 2026
Connect
Our influential series of B2B conferences and expos bridge the gap between cannabis and the mainstream. They provide the platform for cannabis businesses, brands, investors and policymakers to connect, get deals done and build ongoing commercial relationships. These pivotal events are attended by thousands of delegates from over 50 countries annually.
Content
Our reliable and credible data on commercial opportunities, market size and the regulatory environment in key cannabis markets globally provides our 300,000 monthly readers with actionable business insights. This global community also trusts our respected range of digital media titles to keep them informed on the latest industry developments through a variety of multimedia content.
Commerce
Through technology, we’re removing many of the barriers preventing exponential growth for Europe’s cannabis industry and the businesses that operate within it. We’re powering cannabis commerce by providing a trusted space where buyers can make safe and informed purchases, and sellers can distinguish and grow their business. A space where product quality is obvious and payments are painless.
Data &
Intelligence
B2B Cannabis Technology
Media &
Publishing
Events &
Conferences
About Us
Prohibition Partners is the discovery platform for B2B cannabis with fully integrated solutions across conferences, content and commerce. The company was founded in 2017 with a vision for a legal cannabis industry where the abundant economic, societal and health benefits of the plant can be realised by people around the world.
Our Brands
Our portfolio includes some of the most widely used and respected brands in the global cannabis industry.
Reports
Principles of Clinical Cannabinology: A Comprehensive Guide to Medical Cannabis in Europe
Co-authored by Prohibition Partners and Cannabiscientia SA, this publication is intended to be of support to European healthcare professionals, and all those interested in understanding the medical use of cannabis in Europe. In a single eBook, it provides a comprehensive overview of the science, regulations, medicine and products on the market.
Topics covered include the physiology of the endocannabinoid system, the pharmacology of cannabis and its clinical relevance for a number of pathologies. The Handbook also includes case studies and practical evidence of experienced prescribers around the globe that can serve as a guiding support in the obstacles of translating theory to practical applications.
Latest Insights
Events & Conferences
Cannabis Europa
Location: Paris, France
Date: 19 Feb, 2026
Join 1,500+ influential leaders from thriving cannabis companies, investors actively deploying capital into the market, plus key politicians — the crucial combination needed to drive the European cannabis industry and your business forward.
Business of Cannabis: New York
Location: New York
Date: TBA
Presented by Prohibition Partners, Business of Cannabis: New York will bring together the most influential leaders in policy, business, retail, and finance to focus on the new capital of cannabis: New York.
As Trusted By
Insights
on the global cannabis industry
International Cannabis Weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry. Join our community of 80,000+ subscribers.